Name | IHMT-TRK-284 |
---|
Description | IHMT-TRK-284 (Compound 34) is a potent, orally active type II TRK kinase inhibitor with IC50 values of 10.5, 0.7, and 2.6 nM to TRKA, B, and C respectively. IHMT-TRK-284 displays great selectivity profile in the kinome and good in vivo antitumor efficacies[1]. |
---|---|
Related Catalog | |
Target |
TrkB:0.7 nM (IC50) TrkC:2.6 nM (IC50) TrkA:10.5 nM (IC50) PDGFRα:24.2 nM (IC50) PDGFRβ:95.7 nM (IC50) Abl1:83.6 nM (IC50) CSF1R:1.2 nM (IC50) KIT:2167 nM (IC50) |
References |
Molecular Formula | C25H27N7OS |
---|---|
Molecular Weight | 473.59 |